🚨New opportunity for fellows and early investigators in #pedsrheum:
The first Pediatric Rheumatology Early Inestigator Meeting (PREIM) is taking place before PRSYM this March! Hope to see you there!
#RheumSky #PREIM26
www.instagram.com/p/DT0g4g8AIC...
It was great seeing so many people in person and learning together at #ACR25!
Time to get back to this view
I’m looking forward to seeing the pediatric data
I did not turn down puppy time, but I’d support the addition of cats to #ACR26.
Got to meet the puppies at #ACR25! They are here until 4 today.
Dr. Bas Vastert, Care Transformation in Childhood Arthritis via Precision Medicine: sJIA treatment
⭐️cytokine monitoring, especially IL-18
⭐️T2T with biologic first approach in Netherlands- most patients don’t receive any GCs
#ACR25 #ACRambassador
Dr. Bas Vastert, Care Transformation in Childhood Arthritis via Precision Medicine: Window of opportunity
⭐️in non-systemic #JIA: ⬆️ inactive disease with earlier biologic start (<6mo)
⭐️in sJIA: integrating biomarkers in clinical care, early targeted tx
#ACR25 #ACRambassador
Dr. Rae Yeung, Understanding and Harnessing the Biology of Arthritis
4. Naming is important because guides therapy
#ACR25 #ACRambassador #kidsgetarthritistoo
Dr. Rae Yeung, Understanding and Harnessing the Biology of Arthritis
3. UCAN Biologic Classification: lots of patients and large amount of data yielded 5 clusters with clinical and biologic characteristics and distinct patterns of joint involvement
#ACR25 #ACRambassador
Dr. Rae Yeung, Understanding and Harnessing the Biology of Arthritis
2. Clinical exam doesn’t tell the whole story. Concern= patients with subclinical disease but high cytokine levels.
#ACR25 #ACRambassador
Dr. Rae Yeung, Understanding and Harnessing the Biology of Arthritis
1. JIA classification has been a journey. Not every patient finds a home, & peds doesn’t consistently translate to adult classification. Is there a way to do this from a biologic basis?
#ACR25 #ACRambassador
Looking forward to starting my day off in the Networking Lounges for the AMIGO event at 8:20 AM. Hope to see many fellow #pedsrheum there!
#ACR25 #ACRambassador #pedsrheumsky
She is amazing! Glad you were able to make her talk!
We cannot just screen for SDOH needs and do nothing about it. Then it's just more clicking and checkboxes in the EMR. There need to be resources. Or someone knowledgeable about the resources.
#ACR25
Looks delicious!
Dr. Karen Onel presents #ACR25 #pedsrheum Clinical Year in Review: Social Media
🚨 opportunity for increased healthcare provider engagement
#ACRambassador
Dr. Karen Onel presents #ACR25 #pedsrheum Clinical Year in Review: Understanding Disease
-ANA positive ITP patients have higher rates of SLE and Sjogren
-Specific inborn errors of immunity are at increased risk of ANCA and AAV features
#ACRambassador
Dr. Karen Onel presents #ACR25 #pedsrheum Clinical Year in Review: Guidelines
-EULAR/PReS Still’s Guidelines
-French protocol for treatment of #JIA
-ACR Guidance for Mental Health
#ACRambassador
Dr. Karen Onel presents #ACR25 #pedsrheum Clinical Year in Review: Medications
-New FDA approvals: emapalumab, guselkumab
-CAR-T cells in #JDM: a child with aggressive JDM achieved remission
-Stem cell transplant: high morbidity, those who survive do well
#ACRambassador
Dr. Karen Onel presents #ACR25 #pedsrheum Clinical Year in Review: Deprescribing
-a large number of patients JIA flare off therapy
-lower uveitis recurrence with slower ADA tapering schedule
#ACRambassador
Dr. Nigrovic presents #pedsrheum Basic & Translational Year in Review at #ACR25:
1. JIA
2. MAS
3. JDM
4. SLE
5. Monogenic diseases
Calling all #pedsrheum researchers at #ACR25!
Hope you can attend this evening's networking event from 4-5 PM. This event is particularly geared for early career investigators and fellows in training.
#pedsrheumsky
Love seeing the ACR Mental Health Guidelines highlighted!
Drs. Linda Hiraki and Bonnie Bermas discuss applying 2025 SLE Guidelines to #cSLE
⭐️Peds specific GC dosing: GCs impact physical appearance ➡️ self-identity, mood
⭐️ Mental health screening is 🔑
⭐️Impact on growth
⭐️Monitor school attendance/performance
⭐️Transition
#ACR25 #ACRambassador #pedsrheumsky
The 2025 ACR extrarenal SLE guideline includes 36 graded recommendations
🔑HCQ= standard therapy
🔑GCs to control initial inflammation/flare; taper ASAP
🔑Early use of immunosuppressive therapies
🔑Shared decision making
#ACR25 #ACRambassador
#ACR25 Clinical Year in Review by Dr. Bryant England (2/2): #Lupus
⭐️ 2024 lupus nephritis guidelines recommend triple therapy
⭐️ New option for 3rd therapy to treat lupus nephritis: obinutuzumab
#ACRambassador
#ACR25 Clinical Year in Review by Dr. Bryant England (1/2): #Sjogren
⭐️ “The name has caught up to the science in Sjogren’s.”
⭐️ Potential role for salivary autoantibodies
#ACRambassador
#ACR25 Basic Science Year in Review by Dr. Anne Davidson (3/3):
Emerging conference themes
⭐️ CAR-T: upcoming sessions for #rheumsky and #pedsrheumsky
⭐️AI: resource provided for those interested in learning more
#ACRambassador
#ACR25 Basic Science Year in Review by Dr. Anne Davidson (2/3):
Take home messages about the progression of RA from preclinical to clinical state
#ACRambassador
#ACR25 Basic Science Year in Review by Dr. Anne Davidson (1/3):
🔑 papers from the past 12 months
#ACRambassador
